AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2018
Dec 3, 2018
32552_dirs_2018-12-03_3c91b01b-3e1f-43da-b4dd-3f0890804642.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-11-21
Reporting Person: Marshall Ken W. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-21 | Common Stock | P | 1445 | $10.15 | Acquired | 1445 | Indirect |
Footnotes
F1: Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Board/Management Information
2026
Mar 20
Investor Presentation
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17